NHGRI source snapshot
2018 State Bills Washington 2018 HB 2565
Washington
Retrieved from NHGRI
NHGRI summary
Substitute bill version: Requires the drug utilization review board to consider the safety, efficacy, and cost-effectiveness of drugs and gene therapies in its recommendations to the director of the authority regarding coverage for medical assistance programs. Died.
Source links
- Open the primary link recorded by NHGRI
- View the NHGRI Genome Statute and Legislation Database
- Browse other Washington source records
Legacy link: NHGRI recorded this destination using unencrypted HTTP. The link may be stale or unavailable.
Provenance
Courtesy: National Human Genome Research Institute. This source layer preserves the state, primary link, topic, bill status, and summary retrieved from NHGRI.